Market Cap: $9.56M
LI
Lantern Pharma Inc.
LTRN
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $9.56M
Revolutionizing Antibody-Drug Conjugate Development with AI Lantern Pharma Inc., an innovator in cancer therapies leveraging artificial intelligence (AI), is making substantial strides in the developm…
Lantern Pharma Accelerates ADC Development with AI Innovations Lantern Pharma Inc., an artificial intelligence-driven biotech company, is revolutionizing the landscape of antibody-drug conjugates (ADC…
Lantern Pharma Leverages AI to Revolutionize Antibody-Drug Conjugate Development Lantern Pharma Inc. is making significant strides in the field of cancer therapies through its innovative use of the RA…
Lantern Pharma Advances Glioblastoma Treatment with Promising Preclinical Data for LP-184 Lantern Pharma Inc., an innovative player in the oncology landscape, unveils exciting preclinical data and out…
Lantern Pharma Highlights AI-driven Advancements in Oncology Lantern Pharma Inc., an innovative player in cancer therapy development, continues to make significant strides with its proprietary RADR® A…
Revolutionizing Cancer Therapy: Lantern Pharma's AI Innovations Lantern Pharma Inc., a trailblazer in the application of artificial intelligence for oncology, continues to assert its position in the c…